KORU Medical Systems, Inc. — Form 8-K
Filed August 14, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
KORU Medical Systems amended its by-laws effective February 5, 2026 (filed August 13, 2026). Section 3.05 was revised to allow removal of any director(s) with or without cause by a simple majority shareholder vote at a special meeting, replacing prior language. This lowers the threshold for director removal and increases shareholder control over board composition.
Why this rating
Governance amendment affecting shareholder rights, not business operations, revenue, or material assets. Standard corporate governance adjustment.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.